about
Caring for Pregnant Women with Opioid Use Disorder in the USA: Expanding and Improving TreatmentThe opioid epidemic and neonatal abstinence syndrome in the USA: a review of the continuum of care.Opioid Use Disorder in Pregnancy: Health Policy and Practice in the Midst of an Epidemic.Birth and Neonatal Outcomes Following Opioid Use in Pregnancy: A Danish Population-Based Study.Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome: A Pilot Study.Skin conductance at baseline and postheel lance reflects sympathetic activation in neonatal opiate withdrawalNeonatal abstinence syndrome: Pharmacologic strategies for the mother and infant.Improving Care for Neonatal Abstinence Syndrome.Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-Related Death Rates.An overview of available drugs for management of opioid abuse during pregnancy.Contingency Management Interventions for Tobacco and Other Substance Use Disorders in Pregnancy.Neonatal Abstinence Syndrome: Update on Diagnostic and Therapeutic Strategies.Hepatitis C Virus Infection Among Women Giving Birth - Tennessee and United States, 2009-2014.Male Sex Associated With Increased Risk of Neonatal Abstinence Syndrome.Nonmedical Use of Prescription Opioids among Pregnant U.S. Women.Transmission of risk from parents with chronic pain to offspring: an integrative conceptual model.Non-medical opioid use and sources of opioids among pregnant and non-pregnant reproductive-aged women.Maternal buprenorphine treatment and fetal neurobehavioral development.Neonatal Abstinence Syndrome: Trend and Expenditure in Louisiana Medicaid, 2003-2013.Opioid use disorder during pregnancy in Tennessee: expediency vs. science.Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and GynecoTrends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.Comparison of Neonatal Abstinence Syndrome Manifestations in Preterm Versus Term Opioid-Exposed Infants.Prescribing opioids and psychotropic drugs in pregnancy.The Triple Aim for Neonatal Abstinence Syndrome.Treatment of Prescription Opioid Use Disorder in Pregnant Women.Buprenorphine in Neonatal Abstinence Syndrome.Maternal buprenorphine treatment and infant outcome.The prevalence of pain and analgesia use in the Australian population: Findings from the 2011 to 2012 Australian National Health Survey.Early Prediction Tool to Identify the Need for Pharmacotherapy in Infants at Risk of Neonatal Abstinence Syndrome.Association of maternal and infant variants in PNOC and COMT genes with neonatal abstinence syndrome severity.Language competence and communication skills in 3-year-old children after prenatal exposure to analgesic opioids.The Epidemic of Neonatal Abstinence Syndrome, Historical References of Its' Origins, Assessment, and Management.Early life stress and environmental influences on the neurodevelopment of children with prenatal opioid exposure
P2860
Q26738757-B28DD645-547E-4DE6-8C15-F69E1220995FQ30239085-F1BE5A33-C44F-4A32-B14E-0397D2901AF4Q30249760-65D86F87-EA1F-4384-AFA9-951FD176BADDQ36142245-47A74863-AF0B-4579-B4C1-CF95F39E6E62Q36327652-BC55E906-60D6-4956-8060-D25FA914ADE4Q36563091-BABFA00A-4E99-499F-8908-57C975B05204Q36730570-F7A9070C-EDA0-40D0-9AC8-9EF4AAAD4FA0Q36838250-426C44F2-588F-487F-8945-59F1A3B8AAF2Q37501624-1C96AF9B-2E13-4DFC-9BCF-C42C0B781248Q37637022-0A617BA3-968C-4626-AD93-3E9FA1595098Q38668087-0855590F-473F-4342-AF15-897A75F4125CQ38682392-0DEB8B4B-2700-4DF4-B5E9-5818B903D03DQ38792091-D1060CB1-0834-4AD6-B9F3-C8414C8C2775Q38808057-E9EEB63F-FC42-4783-A2DA-5A7C77C746B0Q38837808-D061930D-1B2F-494C-B663-EBB0FE2639A2Q38845051-36AB6561-F432-408D-B84D-E4B26A4E70E2Q38912664-048569DD-9A47-46A3-9C56-0BFBF4DCCFB2Q38966232-D2AF41C3-9DF5-468E-AC44-C2988517A0F4Q38974923-BCF7A129-DBB3-4476-855D-E68114595A1FQ38983591-77A707BC-A6AC-4A5F-9DB8-F5524B525B26Q39359619-BD2D204B-AC5B-41AB-8317-E55AE2EC7115Q40202958-3E8CD30D-A110-4205-9451-DE5AC0ED8937Q40588443-14B01BCB-0B4B-4C5F-A2E9-B4DB79C81BD8Q42340825-4DC56D61-24BC-4857-8E09-51320280C4F5Q42351001-09FD415D-554A-420B-AB3D-CDEFCEF9DE74Q44343654-915D5036-4F2A-462B-AD41-B7E569E2D3A0Q47653755-1D52F92E-7509-4B0B-BA88-AC73ED8DCF98Q47712360-C0F2D968-417D-43B8-AA0E-75A4A603AADBQ47998623-2DE15F58-897D-438E-9568-7E0986D6BA51Q50650996-C95861E7-B07E-487E-8512-5E6CBCCE3BF8Q51075571-E9DFA9DC-6F5B-476F-A6F1-30A7536100B0Q52311980-F0E8380F-8C72-4719-9BA5-E16D6D5139EDQ52665558-251DA5D2-ED96-48DD-8A57-D8434664D1D3Q57169315-3F4AE874-3D7E-47B8-9015-870E22F458DE
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Prescription opioid epidemic and infant outcomes.
@ast
Prescription opioid epidemic and infant outcomes.
@en
type
label
Prescription opioid epidemic and infant outcomes.
@ast
Prescription opioid epidemic and infant outcomes.
@en
prefLabel
Prescription opioid epidemic and infant outcomes.
@ast
Prescription opioid epidemic and infant outcomes.
@en
P2093
P2860
P356
P1433
P1476
Prescription opioid epidemic and infant outcomes.
@en
P2093
Carlos G Grijalva
E Wesley Ely
Frank E Harrell
Judith Dudley
Katherine E Hartmann
Michael D Warren
Peter R Martin
Stephen W Patrick
William O Cooper
P2860
P304
P356
10.1542/PEDS.2014-3299
P407
P577
2015-04-13T00:00:00Z